Portfolio 10
| Date | Name | Website | Total Raised | Location |
| 10.10.2016 | OncoRespon... | oncorespon... | $153.1M | United Sta... |
| - | MEI Pharma | meipharma.... | $102.5M | United Sta... |
| - | Amal Thera... | amaltherap... | $90.9M | Switzerlan... |
| - | On Target ... | ontargetla... | $21M | - |
| - | Aadi Biosc... | aadibio.co... | $95.5M | United Sta... |
| - | QuantuMDx | quantumdx.... | $2.65M | United Kin... |
| - | Greenbone | greenbone.... | $24.64M | Italy, Emi... |
| - | Gain Thera... | gaintherap... | $58.84M | United Sta... |
| - | Personal G... | personalge... | $202.2M | United Sta... |
| - | NovellusDx | novellusdx... | $6M | - |
News 22
Show more
Mentions in press and media 17
| Date | Title | Description | Source |
| 31.01.2020 | Lyfebulb and Helsinn Announce the Winners of the Third Annua... | MONACO, PRINCIPALITY OF MONACO, AND NEW YORK, NY, USA, January 31, 2020: Lyfebulb, a patient empower... | 3bfuturehe... |
| 15.07.2019 | Helsinn Investment Fund Announces First Exit | Luxembourg, 15 July 2019 Helsinn Investment Fund S.A, SICAR, a fund focused on early-stage investmen... | 3bfuturehe... |
| 19.03.2019 | Winners of the Second Annual Lyfebulb-Helsinn Innovation Sum... | MONACO, PRINCIPALITY OF MONACO and NEW YORK, NY, MARCH 19, 2019: Lyfebulb, a patient-empowerment pl... | 3bfuturehe... |
| 19.02.2019 | Helsinn Investment Fund Invests €1 Million in Gain Therape... | Luxembourg, 19 February 2019: Helsinn Investment Fund S.A, SICAR, a fund focused on early-stage inve... | 3bfuturehe... |
| 12.11.2018 | AMAL Therapeutics finalises CHF 33 million Series B round | The Company will use the funds to progress its lead vaccine (ATP128) toward clinical development a... | startuptic... |
| 30.04.2018 | NovellusDx Announces It Has Completed an Equity Financing of... | Jerusalem, Israel, 30 April 2018 – NovellusDx, the leader in functional genomics, today announced ... | 3bfuturehe... |
| 28.03.2018 | Winners of the Inaugural Lyfebulb-Helsinn Innovation Summit ... | Lorenzo Pradella of GreenBone Ortho, srl has been selected from eleven finalists as the winner of th... | 3bfuturehe... |
| 14.03.2018 | On Target Laboratories Raises Additional Capital from H.I.G.... | WEST LAFAYETTE, Ind. 14 March 2018 – On Target Laboratories, Inc., a privately-held biotechnology ... | 3bfuturehe... |
| 05.09.2017 | AMAL Therapeutics Raises €8 Million (CHF 8.8 Million) in F... | Financing round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment F... | 3bfuturehe... |
| 16.06.2017 | Helsinn Investment Fund Leads the Financial Round in GreenBo... | Lugano, Switzerland, 16 June 2017: Helsinn Investment Fund S.A., a fund focused on early-stage inves... | 3bfuturehe... |
Show more